579 results on '"Tseng, Chia‐Lin"'
Search Results
102. High grade glioma radiation therapy on a high field 1.5 Tesla MR-Linac - workflow and initial experience with daily adapt-to-position (ATP) MR guidance: A first report
103. Friday, June 17, 20229:00 AM - 10:00 AM PP01 Presentation Time: 9:00 AM
104. Chemical Exchange Saturation Transfer MRI for Differentiating Radiation Necrosis From Tumor Progression in Brain Metastasis—Application in a Clinical Setting
105. 77: Outcomes of 30GY in 4 Fractions for Spine Stereotactic Body Radiotherapy
106. 43: Predictive Factors for Survival and Radiation Necrosis in Patients with Recurrent High-Grade Glioma Treated with Re-Irradiation
107. 117: Frameless COBALT60-Based Hypofractionated Stereotactic Radiosurgery (HSRS) for Brain Metastases: Impact of Dose and Volume
108. 83: Dose-Escalated Two-Fraction Spine Stereotactic Body Radiotherapy: 28 GY Versus 24 GY in 2 Daily Fractions
109. 47: Mature Local Control and Reirradiation Rates Comparing Spine Stereotactic Body Radiotherapy to Conventional Palliative External Beam Radiotherapy
110. PSOR08 Presentation Time: 12:05 PM: Prospective Study of Local Relapse Patterns after MR-Assisted Salvage HDR Prostate Brachytherapy
111. Conventionally fully fractionated Gamma Knife Icon re-irradiation of primary recurrent intracranial tumors: the first report indicating feasibility and safety
112. LOCL-16 IMPACT OF MGMT PROMOTER METHYLATION STATUS ON TUMOR DYNAMICS DURING WEEKLY ADAPTIVE RADIOTHERAPY FOR GLIOBLASTOMA
113. Skull phantom‐based methodology to validate MRI co‐registration accuracy for Gamma Knife radiosurgery
114. Prostate Cancer Brain Metastasis: Review of a Rare Complication with Limited Treatment Options and Poor Prognosis
115. International Multi-institutional Patterns of Contouring Practice and Clinical Target Volume Recommendations for Stereotactic Body Radiation Therapy for Non-Spine Bone Metastases
116. Numerical analysis of the solar reactor design for a photoelectrochemical hydrogen production system
117. Two-fraction stereotactic ablative radiotherapy (SABR) versus two-fraction high dose rate (HDR) brachytherapy for localized prostate cancer: Does dose heterogeneity matter?
118. Spine Stereotactic Body Radiotherapy for Prostate Cancer Metastases and the Impact of Hormone Sensitivity Status on Local Control
119. Success of targeted transperineal biopsy in patients on surveillance for grade group 1 prostate cancer
120. sj-docx-1-tct-10.1177_15330338221124695 - Supplemental material for Comparison of Prospectively Generated Glioma Treatment Plans Clinically Delivered on Magnetic Resonance Imaging (MRI)-Linear Accelerator (MR-Linac) Versus Conventional Linac: Predicted and Measured Skin Dose
121. The reactor design for photoelectrochemical hydrogen production
122. Comparison of Prospectively Generated Glioma Treatment Plans Clinically Delivered on Magnetic Resonance Imaging (MRI)-Linear Accelerator (MR-Linac) Versus Conventional Linac: Predicted and Measured Skin Dose
123. Pattern of Recurrence of Glioblastoma Versus Grade 4 IDH-Mutant Astrocytoma Following Chemoradiation: A Retrospective Matched-Cohort Analysis
124. Clinically Delivered Treatment for Glioma Patients on Hybrid Magnetic Resonance Imaging (MRI)-Linear Accelerator (MR-Linac) versus Cone Beam CT (CBCT)-Guided Linac
125. Thermodynamic analysis of a photoelectrochemical hydrogen production system
126. Prognostic Factors Associated With Surviving Less Than 3 Months vs Greater Than 3 Years Specific to Spine Stereotactic Body Radiotherapy and Late Adverse Events
127. Predicting Survival in Patients with Glioblastoma Using MRI Radiomic Features Extracted from Radiation Planning Volumes
128. Pattern of Recurrence of Glioblastoma Versus Grade 4 IDH-Mutant Astrocytoma Following Chemoradiation
129. 158: T-DM1 Increases the Risk of SRS-Induced Radiation Necrosis in HER2 + Breast Cancer
130. 69: Dosimetric Comparison in Malignant Glioma Patients Clinically Treated on Hybrid Magnetic Resonance Imaging (MRI)-Linac (MRL) Versus Conventional Linac
131. 5: Biochemical Failure and Toxicity of Magnetic Resonance Imaging Dose Painting to Dominant Intraprostatic Lesion in Prostate High Dose Rate Brachytherapy
132. 8: Dosimetric Predictors of Toxicity and Quality of Life Following Single Fraction High Dose-Rate Prostate Brachytherapy
133. 48: Intermittent Androgen Deprivation Therapy Plus Comprehensive Stereotactic Radiotherapy for Oligometastatic Prostate Cancer (CROP)
134. 40: Workflow and Initial Experience of Glioma Radiotherapy on a High Field 1.5 Tesla MR-Linac
135. 68: A Prospective Study of Mr-Guided Focal Salvage High Dose-Rate Brachytherapy for Radiorecurrent Prostate Cancer: Updated Results of 30 Patients
136. Chemical exchange saturation transfer MRI in central nervous system tumours on a 1.5 T MR-Linac
137. Clinically Delivered Treatment for Glioma Patients on a Hybrid Magnetic Resonance Imaging (MRI)-Linear Accelerator (MR-Linac) and a Cone Beam CT (CBCT)-Guided Linac: Dosimetric Comparisons with In Vivo Skin Dose Correlation
138. The Initial Step Towards Establishing a Quantitative, Magnetic Resonance Imaging-Based Framework for Response Assessment of Spinal Metastases After Stereotactic Body Radiation Therapy
139. MRI Radiomics to Differentiate Between Low Grade Glioma and Glioblastoma Peritumoral Region
140. Integrated approach for multimorbid patients in a hospitalist setting: Survival analysis of a two-year prospective study
141. Additional file 1 of Method of computing direction-dependent margins for the development of consensus contouring guidelines
142. PO59: Dosimetric Parameters Predictive of Treatment-Related Toxicity in High Dose-Rate Brachytherapy as Monotherapy for Prostate Cancer
143. PP06 Presentation Time: 11:45 AM: A Prospective Study of MR-Assisted Salvage HDR Prostate Brachytherapy with Intra-Prostatic Boost
144. 54 - Spinal Cord Compression
145. PRSOR12 Presentation Time: 12:55 PM
146. ADC, D, f dataset calculated through the simplified IVIM model, with MGMT promoter methylation, age, and ECOG, in 38 patients with wildtype IDH glioblastoma
147. Quantitative Mapping of Individual Voxels in the Peritumoral Region of Glioblastoma to Distinguish Between Tumor Infiltration and Edema
148. Intravoxel incoherent motion (IVIM) modeling of diffusion MRI during chemoradiation predicts therapeutic response in IDH wildtype glioblastoma
149. Prostate high dose-rate brachytherapy as monotherapy for prostate cancer: Late toxicity and patient reported outcomes from a randomized phase II clinical trial
150. Stereotactic Body Radiation Therapy for Nonspine Bone Metastases: International Practice Patterns to Guide Treatment Planning
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.